Mr. Emmanuel Armon

Categories: MedDev Speakers 2023
  • Emmanuel Emori Armon is a pharmacist and a public health professional of twenty-three (23) years of experience in diverse areas of pharmaceutical regulatory affairs. The foremost thirteen (13) years of his career in NAFDAC was in the Investigation and Enforcement Directorate, where he headed the Cybercrime and Miscellaneous Offences (CMO) Unit charged with the responsibility of  strengthening and re-positioning the Directorate’s Activities against the forgery of NAFDAC documents and cyber-related activities on substandard and falsified medicines; coordinating the Directorate’s participation in Operation Opson V and investigating public complaints and post-surveillance activities to ensure that registered products meet prescribed registration standards post-registration.


    He has also been in the Drug Registration and Regulatory Affairs Directorate, where he has been involved in regulatory activities geared towards ensuring access to safe and quality medicines namely:

    • Development of the first controlled medicines regulation gazette. This document prescribed the mandatory context for importers, manufacturers, and regulators.
    • Member of the Technical Working Group (TWG) that worked with United States Agency for International Development (USAID) and United States Pharmacopeia (USP) to develop NAFDAC monitoring and evaluation plan for pharmaceuticals.
    • Member of NAFDAC Technical Working Group on AFCFTA. The TWG was mandated to work with the country’s NAC-AFCFTA on inputs on the implementation plan of the Trade agreement, decisions on the Rules of Origin and workstreams meetings
    • Participated in the review and update of the NAFDAC 5+5 validity policy list and Agency Ceiling List of imported pharmaceuticals. These are 2 critical policies implemented to enhance local manufacturing of Pharmaceuticals.
    • Represented the Agency at the 2022 UNITAID Industrial engagement “access to health innovation” forum in South Africa. UNITAID is a global health organization engaged in funding innovation solutions to prevent, diagnose, and treat diseases more quickly, affordable and effectively, in low- and middle-income countries.


    Presently, Emmanuel is a Deputy-Director and is in charge of the registration of Biologics, Vaccines and Medical Devices in NAFDAC, undertaking the following:

    • Reviewing submissions including dossiers to support registrations of vaccines, biologics and medical devices licencing.
    • Issuing permits for registration samples.
    • Licencing and issuing marketing authorizations
    • Reviewing submission for post-approval variation
    • Issuing approval for post approval variations.

    He is also a WHO-trained in-vitro diagnostic device dossier assessor and NAFDAC’s focal person for WHO Collaborative registration Procedure for medical devices